L-DOPA increases slow-wave sleep duration and selectively modulates memory persistence in older adults

Area of Science:

• Neuroscience
• Sleep Research
• Pharmacology

Background:

• Dopamine agonists like L-DOPA are used to treat Parkinson's disease.
• The precise effects of L-DOPA on sleep and memory consolidation remain unclear.
• Previous research suggests L-DOPA's impact on memory is dependent on its timing relative to sleep.

Purpose of the Study:

• To investigate the hypothesis that L-DOPA enhances memory consolidation by modulating NREM sleep.
• To examine the effects of L-DOPA on sleep architecture and memory in healthy older adults.

Main Methods:

• A double-blind, randomized, placebo-controlled crossover trial was conducted with 35 healthy older adults (65-79 years).
• Participants learned a word list, received L-DOPA or placebo, and underwent a night of sleep with a recognition test before sleep.
• L-DOPA administration occurred during sleep and the practice-recognition test, not initial learning.

Main Results:

• L-DOPA significantly increased slow-wave sleep duration by approximately 11% compared to placebo.
• L-DOPA enhanced spindle amplitudes and NREM spectral power.
• Behaviorally, L-DOPA impaired memory for words presented only once, while effects on re-exposed words were less clear.
• No behavioral effects were observed when L-DOPA was administered solely during encoding or retrieval phases.

Conclusions:

• L-DOPA augments slow-wave sleep in the elderly, potentially influencing coordinated network activity and information selection for storage.
• The findings suggest a complex role for L-DOPA in memory consolidation, with potential clinical implications for sleep and memory modulation.